SCHEMBL3402232

SCHEMBL3402232

COc1cc(OCC(=O)O)ccc1-c1cc(CN(CC(=O)O)CC(=O)O)nc(CN(CCc2ccc(N)cc2)Cc2cc(-c3ccc(OCC(=O)O)cc3OC)cc(CN(CC(=O)O)CC(=O)O)n2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 2/20 0.39
LPAR2 Q9HBW0 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
ADORA2B P29275 3/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
CA9 Q16790 1/20 0.36
GYS1 P13807 1/20 0.36
PPARD Q03181 1/20 0.36
ADORA2A P29274 2/20 0.35
KCNH2 Q12809 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
MAPT P10636 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A1 P68400 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3434668 0.93 LPAR1 (0.37) LPAR1LPAR2L3MBTL1ADORA2BCA12
SCHEMBL18628115 0.88 LPAR1 (0.37) LPAR1LPAR2L3MBTL1PPARGPPARA
SCHEMBL3433506 0.82 LPAR1 (0.35) LPAR1LPAR2L3MBTL1ADORA2BCA12
SCHEMBL8548578 0.80 CTSA (0.45)
SCHEMBL3433166 0.73 LPAR1 (0.31) LPAR1LPAR2
SCHEMBL10535744 0.73 GFER (0.41) CA12CA1CA2CA4CA9
SCHEMBL18677954 0.68 PDK2 (0.34) LPAR1L3MBTL1PPARGPPARACA12
SCHEMBL9356014 0.68 GFER (0.38) PPARGPPARACA12CA1CA2
SCHEMBL12293197 0.67 LTB4R (0.38) PPARGPPARACA1CA2MAPT
SCHEMBL3398146 0.66 PPARG (0.30) L3MBTL1PPARGPPARACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8216856-B2 Luminescent lanthanide labelling reagents and their use ABACUS DIAGNOSTICA OY (FI) 2012-07-10 US disclosed
US-8216856-B2 Luminescent lanthanide labelling reagents and their use ABACUS DIAGNOSTICA OY (FI) 2012-07-10 US disclosed
US-8216856-B2 Luminescent lanthanide labelling reagents and their use ABACUS DIAGNOSTICA OY (FI) 2012-07-10 US disclosed
EP-2052252-B1 LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE ABACUS DIAGNOSTICA OY (FI) 2010-11-10 EP disclosed
EP-2052252-B1 LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE ABACUS DIAGNOSTICA OY (FI) 2010-11-10 EP disclosed
US-20100081211-A1 LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE ABACUS DIAGNOSTICA OY (FI) 2010-04-01 US disclosed
US-20100081211-A1 LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE ABACUS DIAGNOSTICA OY (FI) 2010-04-01 US disclosed
US-20100081211-A1 LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE ABACUS DIAGNOSTICA OY (FI) 2010-04-01 US disclosed
WO-2008020113-A1 LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE ABACUS DIAGNOSTICA OY (FI) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081211-A1 LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE SCLY, SRM, TST LPAR1 3415/4885LPAR2 3306/4885L3MBTL1 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.